Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lifted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 12.7% during the 4th quarter, HoldingsChannel reports. The firm owned 3,469 shares of the medical instruments supplier’s stock after purchasing an additional 390 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Mesa Laboratories were worth $458,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Raymond James Financial Inc. purchased a new stake in shares of Mesa Laboratories during the 4th quarter valued at approximately $32,677,000. Conestoga Capital Advisors LLC raised its position in shares of Mesa Laboratories by 8.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 573,037 shares of the medical instruments supplier’s stock valued at $75,566,000 after buying an additional 43,927 shares during the period. Diamond Hill Capital Management Inc. purchased a new stake in shares of Mesa Laboratories during the 4th quarter valued at approximately $3,512,000. Wellington Management Group LLP purchased a new stake in shares of Mesa Laboratories during the 4th quarter valued at approximately $1,888,000. Finally, Kennedy Capital Management LLC raised its position in shares of Mesa Laboratories by 13.2% during the 4th quarter. Kennedy Capital Management LLC now owns 74,606 shares of the medical instruments supplier’s stock valued at $9,838,000 after buying an additional 8,700 shares during the period. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Mesa Laboratories Stock Down 0.8%

Shares of NASDAQ MLAB opened at $126.94 on Wednesday. The firm has a market cap of $689.79 million, a price-to-earnings ratio of -2.74 and a beta of 0.97. The company has a quick ratio of 0.53, a current ratio of 0.71 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 52-week low of $83.68 and a 52-week high of $155.12. The business’s 50 day moving average is $118.81 and its two-hundred day moving average is $126.57.

Mesa Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date is Friday, May 30th. Mesa Laboratories’s payout ratio is -1.38%.

Insider Buying and Selling at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the sale, the chief executive officer now owns 43,337 shares of the company’s stock, valued at $5,369,887.67. The trade was a 32.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.40% of the stock is owned by corporate insiders.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.